Morning Brief: Long COVID In Kids, Whistleblower Lawsuit, And The Valley

Brasil Notícia Notícia

Morning Brief: Long COVID In Kids, Whistleblower Lawsuit, And The Valley
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 LAist
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 51%

Good morning, L.A. ☀️ Here's what you need to know today.

By this point, most of us are likely familiar with the common symptoms of COVID-19: dry cough, fever, difficulty breathing in more severe cases.

My colleague Jackie Fortiér, who has been reporting on the pandemic since its onset in 2020, writes thatestimated 10% to 20% of that groupOne major difference between long COVID in adults and in children is that young people often don’t develop symptoms upon their initial infection. So if long COVID does strike, it’s not top of mind for pediatricians.It may seem, then, that they “have symptoms for which there is no clear cause,” said Dr.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

LAist /  🏆 606. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

What Everyone Should Understand About Brain FogWhat Everyone Should Understand About Brain FogWhile it may not be possible to cure brain fog, these strategies can help people manage it better
Consulte Mais informação »

FDA approves Remdesivir to treat COVID in young childrenFDA approves Remdesivir to treat COVID in young childrenThe antiviral drug is given as an injection. It was previously approved for patients 12 years of age and older.
Consulte Mais informação »

COVID antiviral approved for young kids but vaccine still not availableCOVID antiviral approved for young kids but vaccine still not availableNearly 1,700 parents and doctors across the country have filed a Citizen Petition calling on the FDA to approve a COVID vaccine for kids under 5. The petition comes on the same day the FDA announced the approval of the antiviral drug remdesivir to treat COVID patients as young as 28 days and weighing about 7 pounds.
Consulte Mais informação »

FDA approves Remdesivir to treat COVID in young childrenFDA approves Remdesivir to treat COVID in young childrenThe antiviral drug is given as an injection. It was previously approved for patients 12 years of age and older.
Consulte Mais informação »

FDA approves COVID drug for children, China deals with uphill COVID battle, and more COVID newsFDA approves COVID drug for children, China deals with uphill COVID battle, and more COVID newsThe US Food and Drug Administration announced Monday that it has expanded approval of the COVID-19 drug remdesivir to treat patients as young as 28 days old. Here's that and more COVID news.
Consulte Mais informação »

One Grim Statistic Lays Bare The Truly Relentless Grip of Long COVIDOne Grim Statistic Lays Bare The Truly Relentless Grip of Long COVIDNot even one in four people have completely recovered from COVID a full year after being hospitalized with the disease, a UK study indicated Sunday, warning that long COVID could become a common condition.
Consulte Mais informação »



Render Time: 2025-03-09 05:47:33